Abstract
Objective: To examine the effects of three nitric oxide synthase inhibitors on survival in a murine sepsis model.Design: Prospective randomized experimental trials.Setting: Laboratory.Subjects: Female Balb/c mice.Interventions:Escherichia coli (108 colony-formingunits/body) were injected into the peritoneal cavities of Balb/c mice. NG-nitro-L-arginine-methyl-ester, NG-monomethyl-L-arginine, or N-iminoethyl-L-ornithine was given at various concentrations, intraperitoneally, one hour before bacterial challenge.Measurements: One hundred and fifteen animals were observed for survival.Results: These inhibitors provided the mice no protection from the bacterial challenge. Notably, pretreatment with NG-nitro-L-arginine-methyl-ester (100 mg/kg i.p.) actually reduced survival time afterE. coli challenge.Conclusions: Inhibition of nitric oxide production improved neither the survival time nor rate in this murine sepsis model.
Similar content being viewed by others
References
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharm Rev 1991; 43: 109–42.
Hibbs JB Jr, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987;138:550–65.
Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87–94.
McCall T, Boughton-Smith NK, Palmer RMJ, et al. Synthesis of nitric oxide from L-arginine by neutrophils. Biochem J 1989;261:293–6.
Rimele TJ, Sturm RJ, Adams LM, et al. Interaction of neutrophils withvascular smooth muscle. J Pharmacol Exp Ther 1988;245:102–11.
Green SJ, Nancy CA, Meltger MS. Cytokine induced synthesis of nitrogen oxides in macrophages. J Leukocyte Biol 1991;50:93–103.
Liew FY, Millot S, Parkinson C, Palmer RMJ, Monchada S. Macrophage killing of Lieshmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 1990;144:4794–7.
Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen Oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621–6.
Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338:1557–7.
Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557–8.
Kilbourn RG, Jubran A, Gross SS, et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990;172:1132–8.
Rees DD, Palmer RMJ, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746–52.
McCall TB, Feelisch M, Palmer RMJ, Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol 1991;102:234–8.
Fukatsu K, Saito H, Fukushima R, et al. Detrimental effects of nitric oxide synthase inhibitor (Nω-nitro-L-arginine-ester) in a murine sepsis model. Arch Sur 1995;130:410–4.
Evans T, Carpenter A, Silva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J Infec Dis 1994;169:343–9.
Robertson FM, Offner PJ, Ciceri DP, et al. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994;129:149–56.
Minnard EA, Shou J, Naam H, et al. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994;129:142–8.
Author information
Authors and Affiliations
Additional information
accepted by R. O. Day
Rights and permissions
About this article
Cite this article
Fukatsu, K., Saito, H., Fukushima, R. et al. Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection. Inflamm Res 45, 109–112 (1996). https://doi.org/10.1007/BF02265161
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02265161